52820-49-2 Usage
Uses
Used in Organic Synthesis:
3-Carbamimidoyl-benzoic acid is utilized as a key intermediate in organic synthesis for the preparation of various organic compounds. Its unique structure allows for the formation of diverse chemical entities, contributing to the advancement of the chemical industry.
Used in Drug Development:
In the pharmaceutical sector, 3-Carbamimidoyl-benzoic acid is employed as a precursor in the synthesis of medicinally relevant compounds. Its potential to form pharmacologically active molecules makes it a valuable asset in the discovery and development of new drugs.
Used in the Production of Dyes and Pigments:
3-Carbamimidoyl-benzoic acid also finds application in the manufacturing process of dyes and pigments, where its chemical properties are harnessed to produce a range of colorants used in various industries.
Overall, 3-Carbamimidoyl-benzoic acid is a multifaceted chemical entity with significant applications across different industries, underpinning its importance in the development of pharmaceuticals and organic chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 52820-49-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,8,2 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52820-49:
(7*5)+(6*2)+(5*8)+(4*2)+(3*0)+(2*4)+(1*9)=112
112 % 10 = 2
So 52820-49-2 is a valid CAS Registry Number.
52820-49-2Relevant academic research and scientific papers
Benzene compounds
-
Page/Page column 70, (2010/11/27)
The present invention provides novel benzene compounds presented by the following formulas, and analogs thereof, that exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hypertension, arteriosclerosis), hypertension, and arteriosclerosis.
Meta-benzamidine derivatives as serine protease inhibitors
-
, (2008/06/13)
Compounds of formula I in which R1, R2, R3, each X, L, Y, Cy, Lp, D and n have the meanings as set out in the specification, and corresponding compounds in which the unsubstituted or substituted amidine group is replaced w
From molecules to the crystalline solid: Secondary hydrogen-bonding interactions of salt bridges and their role in magnetic exchange
Papoutsakis, Dimitris,Kirby, James P.,Jackson, James E.,Nocera, Daniel G.
, p. 1474 - 1480 (2007/10/03)
The primary two-point hydrogen=bond contact of p-substituted benzamidinium cations to benzoate anions in [D6]DMSO forms a salt bridge as described by a classical Hammett relation. At carboxylate: amidinium proportions greater than 1:1, amidiniu
